Molnupiravir, also known by its brand name MK-4488, represents a notable advancement in the effort against COVID-19. This oral antiviral drug works by introducing errors into the SARS-CoV-2's genetic code, effectively https://finnianbgnl498884.wikimidpoint.com/6974538/molnupiravir_a_coronavirus_medication_approach